Comprehensive assessment of side effects in COVID-19 drug pipeline from a network perspective

Currently, coronavirus disease 2019 (COVID-19), has posed an imminent threat to global public health. Although some current therapeutic agents have showed potential prevention or treatment, a growing number of associated adverse events have occurred on patients with COVID-19 in the course of medical...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qihui, Fan, Xiude, Hong, Honghai, Gu, Yong, Liu, Zhihong, Fang, Shuhuan, Wang, Qi, Cai, Chuipu, Fang, Jiansong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505223/
https://www.ncbi.nlm.nih.gov/pubmed/32971210
http://dx.doi.org/10.1016/j.fct.2020.111767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505223/
https://www.ncbi.nlm.nih.gov/pubmed/32971210
http://dx.doi.org/10.1016/j.fct.2020.111767

Ejemplares similares